23andMe’s Wojcicki Assists Covid-19 Fight With Analytics

The transcript covers a conversation with the CEO of 23andMe about their role in COVID-19 research, genetic findings, and public health implications. It discusses data sharing with entities like the FDA and CDC, the company's origins, challenges, and consumer choice in healthcare. The transcript also explores discoveries about ancestry and family connections, and the future of 23andMe, including potential public offerings.

What challenges did the founder face when starting 23andMe?

How does 23andMe ensure consumer choice in health information?

How has 23andMe impacted individuals' understanding of their ancestry?

What is the current number of people who have provided their saliva to 23andMe?